Myriad breast cancer patent very broad, study finds
(Reuters) Myriad Genetics' disputed patent on the BRCA1 breast cancer gene is "surprisingly broad" and could interfere with future research, three experts said on Tuesday.
Dr. Murray Feingold: Drugs made just for you
(Daily News Transcript) Patients with the same diagnoses are usually treated with similar medications. However, not all patients respond the same way to the same treatment. Some get better, others do not.
Euthanasia's Slippery Slope
(The Mark) For millennia, euthanasia has been considered morally and legally unjustifiable. People who oppose euthanasia still believe it's inherently wrong – it can't be morally justified and even compassionate motives don't make it ethically acceptable. But what are the attitudes of pro-euthanasia advocates regarding whether its use needs to be justified, were it to be legalized? And, if justifications are required, what are they?
The ethics of paying kidney donors
(WHYY News) A new study seems to knock down some of the ethical objections to paying people to donate an organ. The study authors are with the University of Pennsylvania and the Philadelphia VA Medical Center.
With Medicaid Cuts, Doctors and Patients Drop Out
(New York Times) As she began a punishing regimen of chemotherapy and radiation, Mrs. Vliet found a measure of comfort in her monthly appointments with her primary care physician, Dr. Saed J. Sahouri, who had been monitoring her health for nearly two years. She was devastated, therefore, when Dr. Sahouri informed her a few months later that he could no longer see her because, like a growing number of doctors, he had stopped taking patients with Medicaid.
